Down-regulation of MIR-3206 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer

Growth Factors

Volumn 33, Issue 4, 2015, Pages 267-274

  Li, Yanliang ^a   Gao, Yongsheng ^a   Xu, Yue ^b   Ma, Heng ^a   Yang, Mingshan ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Wucheng Peoples Hospital   (China)

Author keywords

FSCN1; gastric cancer; MIR 326; prognosis

Indexed keywords

FASCIN; FASCIN 1; MESSENGER RNA; MICRORNA; MICRORNA 326; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ACTIN BINDING PROTEIN; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; MIRN326 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FOLLOW UP; GAIN OF FUNCTION MUTATION; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MTT ASSAY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH; STOMACH CANCER; TUMOR GROWTH; VERY ELDERLY; WESTERN BLOTTING; ADOLESCENT; CELL MOTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL MOVEMENT; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; STOMACH NEOPLASMS;

EID: 84942191553     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2015.1076406     Document Type: Article

References (27)

1. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297
2. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, He J. 2013. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 32: 106-112
3. Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, et al. 2014. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J Transl Med 12: 259
4. Fang XY, Pan HF, Leng RX, Ye DQ. 2015. Long noncoding RNAs: Novel insights into gastric cancer. Cancer Lett 356: 357-366
5. Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang W, Li L. 2014. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer 110: 2300-2309
6. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, et al. 2008. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 27: 2616-2627
7. Fu H, Wen JF, Hu ZL, Luo GQ, Ren HZ. 2009. Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells. Pathology 41: 655-660
8. He L, Hannon GJ. 2004. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531
9. Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP. 2014. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Gene 552: 255-264
10. Kefas B, Comeau L, Erdle N, Montgomery E, Amos S, Purow B. 2010. Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol 12: 1102-1112
11. Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, Jiang J, et al. 2009. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 29: 15161-15168
12. Kim SJ, Kim DC, Kim MC, Jung GJ, Kim KH, Jang JS, Kwon HC, et al. 2012. Fascin expression is related to poor survival in gastric cancer. Pathol Int 62: 777-784
13. Kim Y, Kim H, Park H, Park D, Lee H, Lee YS, Choe J, et al. 2014. miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs. J Biol Chem 289: 28019-28039
14. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, et al. 2010. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79: 817-824
15. Ma J, Wang T, Guo R, Yang X, Yin J, Yu J, Xiang Q, et al. 2015. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1. J Drug Target 23: 1-6
16. Meyer HJ, Wilke H. 2011. Treatment strategies in gastric cancer. Dtsch Arztebl Int 108: 698-705; quiz 706
17. Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin 65: 5-29
18. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108
19. Tsai WC, Jin JS, Chang WK, Chan DC, Yeh MK, Cherng SC, Lin LF, et al. 2007. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: Correlation with clinicopathological parameters. J Histochem Cytochem 55: 955-962
20. Wang R, Chen XF, Shu YQ. 2015. Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics. Am J Cancer Res 5: 32-51
21. Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B. 2013. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30: 373
22. Wu L, Hui H, Wang LJ, Wang H, Liu QF, Han SX. 2015. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein. Oncol Rep 33: 2309-2318
23. Zamore PD, Haley B. 2005. Ribo-gnome: The big world of small RNAs. Science 309: 1519-1524
24. Zhang ZL, Bai ZH, Wang XB, Bai L, Miao F, Pei HH. 2015. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. PLoS One 10: e0118814
25. Zhang R, Wang W, Li F, Zhang H, Liu J. 2014. MicroRNA-106b∼25 expressions in tumor tissues and plasma of patients with gastric cancers. Med Oncol 31: 243
26. Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang X, Huang Y, et al. 2013. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One 8: e68469
27. Zhou S, Yang B, Zhao Y, Xu S, Zhang H, Li Z. 2014. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma. J Surg Res 192: 515-520